Apple's latest patent targets blood pressure monitoring; FTC may be investigating 23andMe, & more — 9 health IT key notes

Here are nine recent news updates on health IT companies:

1. The Federal Trade Commission is reportedly investigating various direct-to-consumer genetic testing companies, including market giants 23andMe and, over data privacy concerns.

2. Apple may soon offer a wearable device that monitors blood pressure, according to a U.S. patent application made public June 6.

3. MedTech Breakthrough released the winners of its 2018 MedTech Breakthrough Awards, which included companies like Apple and Vocera Communications, June 6.

4. Epic approved HealthPay24's payment page for its App Orchard, the patient financial engagement company confirmed June 12.

5. Google CEO Sundar Pichai penned a blog post June 7 outlining seven principles guiding the company's work related to artificial intelligence.

6. The popular meditation app Headspace recently launched a subsidiary dubbed Headspace Health, which aims to build a suite of prescription-level apps that address several health conditions.

7. Medical staffing and home nursing services provider Maxim Healthcare Services reached a five-year agreement with Leidos to create a suite of health IT solutions focused on the home, post-acute and long-term care settings.

8. Microsoft unveiled the winners of its 2018 Partner of the Year Awards June 7, one of which was Cognizant Technology Solutions.

9. Protenus named Brian Holtmeier its CFO, the healthcare analytics platform confirmed June 6.

More articles on health IT:
Epic adds HealthPay24 payment tool to App Orchard
The Sequoia Project updates patient matching framework
CRISPR gene editing may increase cancer risk in humans, two studies suggest

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers